Will you be in Berlin for the @worldhealthsummit.bsky.social? CEPI is organising a thought-provoking panel entitled “Preparing for Future Pandemics – From Fragmentation to Cohesion” on 12 October 2025, 16:00–17:30 CEST ⬇️ bit.ly/3WvE9TI

New topline data from a clinical trial co-funded by CEPI assessing Bavarian Nordic's Mpox vaccine in children found that the vaccine was safe and generated an immune response not-inferior to when vaccinating adults. Our new blog looks at the breadth of our work tackling the deadly Mpox virus⤵️

New $1 million CEPI funding to AVAREF will invite regulators and ethicists to AVAREF joint review processes and simulation exercises to optimise the speed at which clinical trials of infectious disease vaccines are approved in Africa⤵️ cepi.net/cepi-partner...

Could a single vaccine protect people against Zaire ebolavirus, Marburg and Sudan ebolavirus – some of the deadliest viruses known to humankind? A CEPI-funded project is set to find out…

Could a single vaccine protect people against Zaire ebolavirus, Marburg and Sudan ebolavirus – some of the deadliest viruses known to humankind? A CEPI-funded project is set to find out…

📅 Don't miss @cepi.net #WHS2025 event, Preparing for Future Pandemics: From Fragmentation to Cohesion on 12 Oct! Not going in person? Tune into the livestream 📺 www.worldhealthsummit.org/sessions/7ac...

How can #AI accelerate vaccine development and strengthen pandemic preparedness? This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.

New research in Nature Communications reveals that all-in-one coronavirus vaccines could save millions of lives, dramatically reduce economic disruption and limit the need for lockdowns in future pandemics ⬇️

Future pandemics demand future-ready tools. That’s why CEPI is planning to develop a revolutionary new artificial intelligence platform called the Pandemic Preparedness Engine – a kind of ChatGPT dedicated to accelerating pandemic vaccine development ➡️ bit.ly/3WfakGS

What's been happening in the world of epidemic and pandemic preparedness this month? Find out in CEPI's September newsletter 🗞️

Future pandemics demand future-ready tools. That’s why CEPI is planning to develop a revolutionary new artificial intelligence platform called the Pandemic Preparedness Engine – a kind of ChatGPT dedicated to accelerating pandemic vaccine development ➡️ bit.ly/3WfakGS

CEPI is partnering with UKHSA & Fondation Mérieux through two new framework agreements aimed at strengthening biosecurity capacities in the DRC, supporting CEPI’s existing R&D partners in the region. 📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.

From vaccine breakthroughs and our role in COVAX, to driving forward the 100 Days Mission and lots more, explore CEPI's progress and results, so far, below ⬇️ cepi.net/our-impact/p...

📺💡A new BBC Horizon documentary, ‘Disease X: Hunting the next pandemic’ delves into the potential deadly threat of a future unknown disease that could spread globally – and the possible culprit viral families it could come from, such as a virus related to the deadly Nipah or influenza strains (1/3)

What role can regional & global partnerships play in responding to future outbreaks? How can Africa strengthen its vaccine sovereignty? Which breakthroughs will accelerate vaccine access? Speaking with @nigeriahealthwatch.bsky.social, CEPI's Dr Amadou Sall shares his thoughts on these questions ⬇️

If we were to achieve our #100DaysMission, we could stay one step ahead of infectious diseases and outbreaks could be stopped before they ever spiralled into pandemics. More on our website ⬇️

In this Innovation for Impact story, discover how CEPI's funding is helping Africa achieve vaccine sovereignty, driven by expertise from regional partners like Senegal's Institut Pasteur de Dakar 🇸🇳

Congratulations to the inaugural cohort of Biosecurity Game Changers Fellows! Over the last year, 8 fellows worked across the globe partnered with leading organizations to advance global #biosecurity. More via @brownpublichealth.bsky.social ⤵️

The reach of the potentially deadly #RiftValley fever is expanding, yet no vaccines are currently approved for human use. We’re looking to change that ⬇️

📣 Four global health and science experts, widely recognised for their contributions in tackling deadly infectious disease threats, have been appointed to key governance positions at CEPI. ▶️ cepi.net/top-health-a...

Did you know the next pandemic is likely to emerge from one of 25 or so viral families? Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat. Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...

📣We're providing up to $10.4 million to work with international partners and gather real-world insights into the use of the Lc16m8 vaccine in protecting against mpox in the DRC. The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...

New @weforum.org article, co-authored by CEPI's Director of Biosecurity, Andrew Hebbeler, explores the latest international initiatives shaping the norms and practices required to embrace AI innovation in the bioeconomy safely, responsibly and equitably. @ibbis-bio.bsky.social Check it out ⬇️

In an historic moment for regional solidarity, West African Ministers of Health today pledged their joint commitment to advance the development of, and readiness for, much-needed vaccines to tackle Lassa fever.

We've joined UC Davis Grand Challenges and UC Davis Health to partner with @cepi.net and @bostonu.bsky.social's BEACON project to integrate #AI with expert knowledge for ranking #viruses with the pandemic potential. cepi.net/new-global-c...

Are you an academic institute, public sector agency, biotech, or pharmaceutical company interested in applying to one of our open Calls for Proposals? Check out our website for more details and how to apply ⏬ https://bit.ly/3TlFtr9

📣We're working with experts at VISTA (UC Davis) and BEACON (@buceid.bsky.social) to combine their AI and infectious disease knowledge to more accurately rank the viruses that have the potential to cause the next deadly pandemic.

Our #100DaysMission aims to shorten vaccine development timelines to 100 days. Had this been achieved for COVID-19, a vaccine could have been available as early as April 2020. This would have saved millions of lives and minimised economic crisis. vimeo.com/649928162?fl...

Check out CEPI's August newsletter 🗞️ This month, we feature two landmark moments in the fight against the potentially deadly Rift Valley fever: the launch of a Phase II Rift Valley fever vaccine trial and new epidemiology and modelling studies that will help shed light on its true disease burden.

TIME puts rapid vaccine development front and centre for its latest feature '10 AI Applications Shaping the Future' With insight from CEPI's Timothy Endy, the article highlights how AI-powered tools are helping accelerate vaccine development timelines.

Developing safe, high-quality, scalable vaccines in 100 days? It’s possible. CEPI’s new CMC Rapid Response Framework shows how to accelerate Chemistry, Manufacturing & Controls (CMC) for pandemic-ready vaccines. Read more ⬇️

📣Attending the ECOWAS Lassa Fever International Conference in Cote d’Ivoire next month? Join us for our ‘Regional readiness for Lassa fever vaccines: Development to Access' session on Tuesday 9 September 8.30-10.00 AM GMT.

One year on from #mpox being declared a public health emergency – where are we now?

We're bringing together some of the greatest minds in Rift Valley fever research for two pioneering African-led $9.6m studies using epidemiology and computer modelling to map out the disease's impact across Africa and support vaccine development efforts ⤵️ cepi.net/landmark-afr...

DYK: Mosquitoes cause more human deaths than any other creature each year 🦟 #WorldMosquitoDay Vectors of viruses like dengue, Zika, chikungunya and malaria, mosquitoes contribute to around 700,000 deaths each year, according to @who.int. And their geographic reach is spreading...

New vaccine milestone reached for Rift Valley fever 💉 On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)

New vaccine milestone reached for Rift Valley fever 💉 On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)

New $6.4M @utmbhealth.bsky.social CEPI-funded project, UNVEIL, will work with partners in Nigeria and Sierra Leone to identify the immune responses that protect against Lassa fever, a key step toward effective vaccines. bit.ly/3J8K79U

The success of the 100 Days Mission relies on establishing an enabling regulatory environment. One that can go even faster than the COVID response, whilst maintaining appropriate levels of regulatory oversight. CEPI regulatory experts describe some routes to achieving this ⬇️ bit.ly/47p4rO6

Did you know #AI is already helping the world get ahead of the next pandemic threat? This isn’t about the future, it’s happening now. Discover how CEPI-backed scientists are applying AI to help design better outbreak vaccines faster than ever ⬇️ bit.ly/4kU9s4x

💡Enable 1.5 is a pioneering CEPI study working to advance our understanding of Lassa virus and help inform Lassa fever vaccine development. Read the study protocol, now in @bmj.com Public Health: bmjpublichealth.bmj.com/content/3/2/... 📸 Enable 1.5 participants in Nigeria | Nigeria CDC.

From @brownpublichealth.bsky.social: Biosecurity Game Changer Sana Masmoudi has been in partnership with @cepi.net over the last year advancing global standards and supporting CEPI’s #100DaysMission to rapidly respond to the next outbreak and so much more! Read here 👇

#Chikungunya is a mosquito-borne disease belonging to the togavirus viral family🦠 It is spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus🦟

📣 Korea's Disease Control and Prevention Agency and International Vaccine Institute (IVI) are joining our Centralised Labs Network, the world's largest group of laboratories working to standardise the assessment of new infectious disease vaccines 🇰🇷 cepi.net/leading-scie...

Scientists have launched the first-ever library of adjuvants, substances that improve vaccines' ability to create immunity. The project aims to support the 100 Days Mission to boost our ability to rapidly develop vaccines for emerging threats. @cepi.net www.ghtcoalition.org/blog/researc...

In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners helped to quickly end the outbreak, with a Marburg vaccine deployed in an emergency clinical trial just 10 days after the outbreak was declared ⬇️ bit.ly/45zSaoM

In late 2024, Marburg virus hit Rwanda for the first time. A new NPJ Vaccines article details how CEPI and partners helped to quickly end the outbreak, with a Marburg vaccine deployed in an emergency clinical trial just 10 days after the outbreak was declared ⬇️ bit.ly/45zSaoM

📣We’re launching the world's first library of adjuvants that can be ‘taken off the shelf’ and used to develop new epidemic and pandemic vaccines. Hosted by the UK's MHRA, the $2.5 million project will help developers select the best vaccine-adjuvant combinations: cepi.net/world-first-...

In this new piece, Dr Victor Dzau, Co-Chair of @ippsecretariat.org, explores global progress made toward the 100 Days Mission—a goal to produce diagnostics, therapeutics, and vaccines within 100 days of identifying a viral threat with pandemic potential. bit.ly/41jGqnL.

What do a coffee pod and a moth have to do with speeding up vaccine development and helping ensure equitable access to vaccines during a future outbreak? ☕🦋 Find out ⬇️ bit.ly/435a7ux